StoneX Group Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
StoneX Group Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$421,000
+8.2%
7,5160.0%0.22%
+12.1%
Q2 2022$389,000
-60.5%
7,516
-9.8%
0.20%
+68.6%
Q4 2021$985,000
-26.6%
8,330
-16.7%
0.12%
-38.9%
Q3 2021$1,342,000
-29.7%
10,001
-15.2%
0.19%
-31.8%
Q2 2021$1,909,000
+84.8%
11,792
-8.4%
0.28%
+52.2%
Q1 2021$1,033,000
+37.0%
12,877
-7.1%
0.19%
+12.0%
Q4 2020$754,000
+163.6%
13,867
-3.6%
0.17%
+80.4%
Q3 2020$286,000
-5.9%
14,382
-0.7%
0.09%
-20.0%
Q2 2020$304,000
+66.1%
14,482
-3.3%
0.12%
+18.6%
Q1 2020$183,000
-16.8%
14,9820.0%0.10%
+7.8%
Q4 2019$220,000
+0.9%
14,982
-8.2%
0.09%
-33.8%
Q3 2019$218,000
-21.0%
16,317
-3.2%
0.14%
-23.2%
Q2 2019$276,000
-8.0%
16,852
-4.0%
0.18%
-22.4%
Q1 2019$300,000
+22.0%
17,552
-2.5%
0.23%
-3.8%
Q4 2018$246,000
-56.6%
17,995
-9.1%
0.24%
-43.7%
Q3 2018$567,000
+1.1%
19,798
-3.4%
0.42%
-12.8%
Q2 2018$561,000
+35.5%
20,495
+4.5%
0.48%
+22.0%
Q1 2018$414,000
+17.3%
19,620
+6.8%
0.40%
+7.6%
Q4 2017$353,00018,3650.37%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders